Is VXXV11 worth it? Analysis of Genesis Multiestratégia FII
Recommendation: SELL · Rating 2.4/10
Analysis and recommendation
The VXXV11 is a closed-end institutional vehicle with only 15 unitholders — 1 corporate unitholder holds 57%. It has not distributed since Nov/2020 (except for a partial principal repayment in May/2024) and registered a loss of R$ 84.8M in 2025, with the auditor issuing a qualified opinion on 80% of net assets. The Q2/26 Quarterly Report (reference date 06/2026) shows cash practically depleted — down from R$ 19.1M to R$ 100, leaving only R$ 1.3M in a fixed-income fund to cover the management fee. Price of R$ 756 (P/BV of 1.59 with a 0% dividend yield) is residual pricing of a vehicle with near-zero liquidity. Verdict: this fund was not designed for retail investors — entering via the order book is a liquidity trap with expected losses.
Investment thesis
The VXXV11 was NOT designed for retail investors. It is a closed-end institutional vehicle (15 unitholders, 1 with 57%) that operates as a structured workout — receiving real estate assets and SPEs tied to defaulted Habitasec CRIs via payment-in-kind. Price of R$ 756 (vs book value of R$ 475) reflects residual liquidity, not informed trading. Anyone buying through the order book pays a 59% premium over book value, with no income for 17 months, exposed to 80% of net assets with auditor qualifications. For retail investors: simply no.
Who it's for
Institutional unitholders already positioned (investment funds that entered via structured private offerings)
Eventually a professional/qualified investor in private over-the-counter transactions — not via the order book
Anyone who understands defaulted Habitasec CRI workouts and accepts an indefinite monetization timeline
NO other category identified — fund does not meet the requirements (50+ unitholders, no concentration >10%) for retail tax exemption
Who it's not for
Retail investors in any profile — fund is structurally a corporate entity and does not provide income tax exemption to individuals (due to having fewer than 50 unitholders)
Income investor — has not distributed for 17 months and there is no clear prospect of resumption
Value investor (P/BV) — book value is accounting-based and carries auditor qualifications on 80% of assets; the "discount" is not real
Anyone seeking liquidity — 1 unit traded on a few recent business days (May/2026); average daily trading volume close to zero
Anyone buying by looking at the price on the screen — R$ 756 is not an equilibrium price; it is a residual
Points of attention and risks
Cash practically depleted — from R$ 19.1M to R$ 100 in one quarter
The Q2/26 Quarterly Report shows Cash and Cash Equivalents of R$ 100.00 (compared to R$ 19,116,905 in Q1). Only R$ 1.3M remains in a fixed-income fund to cover the management fee (~R$ 353k/quarter). Cash was likely drained to acquire the new position KRONOLOG II SENIOR (R$ 33.3M). Without operating cash generation, the structure has a short runway without monetizing assets or receiving a new capital call.
Only 15 unitholders — essentially a closed-end fund
In Mar/2026: 15 unitholders (1 REIT-style fund (FII) + 14 other funds), with 1 corporate unitholder holding 272,479 units (57.02%). Does not meet the 50+ unitholder requirement for individual income tax exemption — structurally incompatible with retail.
Accounting loss of R$ 84.8M in 2025
Financial statements audited by CLA: net loss of R$ 84.8M in 2025 (R$ 34.2M up to 10/17 + R$ 50.5M after transfer). Main cause: negative fair value adjustment of REIT-style fund (FII) units (-R$ 102M). The bleeding continues: the accumulated first-half 2026 financial result was -R$ 20.0M (Q2/26 — CVM ID 1290706).
Auditor opinion with qualifications on 80% of net assets
CLA issued a qualified opinion on 03/30/2026: (i) Rec Log 2 (15.6% of net assets) — DCF assumptions not verifiable; (ii) BW Diase Fortaleza (64.3% of net assets) — without audited financial statements as of the report date. Total: 79.9% of net assets with contested accounting quality.
No distribution in 2025 — and second consecutive zero semester
In 2025 distributed 0%. The Q2/26 Quarterly Report confirms declared income payments of R$ 0 and income payable of R$ 0 — second consecutive semester without any distribution. Annual cash-basis profit (2025): R$ 999k (≈0.4% of net assets), entirely retained.
Shopping Iguatemi São Carlos with 90% vacancy — 100% of the REIT-style fund's (FII) revenue
Sole direct property. Vacancy maintained at 90% in Q2/26, accounts for 100% of the fund's rental revenue (R$ 144.6k in the quarter, vs R$ 158.4k in Q1). Delinquency 0%, but revenue is negligible relative to net assets.
Fourth administrator change since IPO
VORTX → Trustee → BRL Trust (APEX) on 10/18/2025. 2025 financial statements split into two periods. Management also changed (Vinci VX XVI → Genesis Capital in 2022).
P/BV of 1.59 disconnected from fundamentals
R$ 756 over book value of R$ 475 = P/BV of 1.59. With 15 unitholders and negligible average daily trading volume, this is NOT informed trading (volume 05/11/26: 1 unit). Do not use as a fair value reference.
Concentration in SPE without financial statements + new KRONOLOG II position
BW Diase Fortaleza remains the largest position — increased from R$ 158.9M to R$ 161.9M in Q2/26, without audited financial statements. The KRONOLOG II SENIOR (R$ 33.3M) position appears in Q2, nonexistent in Q1 — likely destination of the drained cash. Meanwhile, the SHOP11 position devalued by -33.6% (R$ 2.59M → R$ 1.72M).
Is VXXV11 trustworthy?
Our current reading of VXXV11 is SELL, with a score of 2.4/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
Genesis with depleted cash (from R$ 19.1M to R$ 100), 15 unitholders, R$ 84.8M loss in 2025, and audit with qualifications on 80% of net assets. Payment-in-kind structure in default.
Is VXXV11 safe?
Safety in a REIT is not yes or no — it is how much risk you accept. VXXV11 has a extremo risk profile. What that means in practice:
Component
Level
Concentração
5.0
Price volatility
3.5
Dividend volatility
5.0
Liquidez
5.0
Underlying asset risk
5.0
Financial/leverage risk
2.0
Scenarios for VXXV11
Scenario
Description
Monetization of the BW Diase SPV in 2-3 years
Genesis manages to lease/sell deed property no. 378/Itaitinga/CE above book value.
Reactivation of Shopping Iguatemi São Carlos
90% vacancy is reversed with a new anchor operation.
New negative fair value adjustment for Kronolog units
Kronolog is a new fund without audited financial statements. March/26 saw -7.87%.
Extraordinary amortization approved by the controlling unitholder (57%)
An investor who bought at R$ 756 would receive the amortization amount (close to the book value of R$ 475).
Liquidation of the fund
Institutional structure may be dissolved at a meeting; retail exchange investors receive book value — immediate loss of ~37%.
Continuation of accounting losses
Net assets may drop below R$ 200M if fair value adjustments continue.
Conclusion
The VXXV11 (Genesis Multiestratégia, ex-VX XVI) is a fund that was never designed for retail investors — 15 unitholders (all investment funds), 1 corporate unitholder holds 57%, and it does not meet the requirements for individual income tax exemption.
Operationally, it has turned into a structured workout vehicle: in May/2024 it absorbed 42% of BWP FII (Habitasec 250 CRI in default); in Dec/2025 it absorbed 100% of BW Diase Fortaleza SPV (Habitasec 305 CRI), which currently represents 64% of net assets without audited financial statements.
Auditor CLA issued a QUALIFIED opinion on the 2025 financial statements — 80% of net assets have questionable accounting quality. The single direct property operates with 90% vacancy and the fund has changed administrators 4 times since the IPO.
The market price of R$ 756 (P/BV 1.59) IS NOT an equilibrium price — it is a residue of sporadic orders. Anyone entering via the exchange screen pays a 59% premium over book value (R$ 475), has received no income for 17 months, and is exposed to a pending audit. In any liquidity event (amortization or liquidation), they lose ~37% immediately.
Frequently asked questions
Is VXXV11 good? Is it worth investing?
Current recommendation: SELL. Rating 2.4/10. The VXXV11 is a closed-end institutional vehicle with only 15 unitholders — 1 corporate unitholder holds 57%. It has not distributed since Nov/2020 (except for a partial principal repayment in May/2024) and registered a loss of R$ 84.8M in 2025, with the auditor issuing a…
VXXV11: buy or sell?
Our current read on VXXV11 is “SELL”. Rating 2.4/10. Assess it against your risk profile and the points of attention listed above.
What are VXXV11's risks?
The main points of attention for Genesis Multiestratégia FII include: Cash practically depleted — from R$ 19.1M to R$ 100 in one quarter; Only 15 unitholders — essentially a closed-end fund; Accounting loss of R$ 84.8M in 2025; Auditor opinion with qualifications on 80% of net assets.
Who is VXXV11 suitable for?
VXXV11 is suitable for: Institutional unitholders already positioned (investment funds that entered via structured private offerings) Eventually a professional/qualified investor in private over-the-counter transactions — not via the order book Anyone who understands defaulted Habitasec CRI workouts and accepts an indefinite monetization timeline